Clinical Trial Update: Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated intravenous immunoglobulin (IVIg) for the treatment of stiff-person syndrome. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stiff-person Syndrome

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Muscle Rigidity, Spasm | Phase 1 | Status: COMPLETED